位置:首页 > 蛋白库 > MED25_MOUSE
MED25_MOUSE
ID   MED25_MOUSE             Reviewed;         745 AA.
AC   Q8VCB2; Q3UDX6; Q3UFQ1; Q6IR27;
DT   02-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2002, sequence version 1.
DT   03-AUG-2022, entry version 137.
DE   RecName: Full=Mediator of RNA polymerase II transcription subunit 25;
DE   AltName: Full=Mediator complex subunit 25;
DE            Short=mMED25;
GN   Name=Med25;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1-522 (ISOFORM 3).
RC   STRAIN=C57BL/6J; TISSUE=Bone marrow;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   STRAIN=FVB/N; TISSUE=Kidney, Mammary tumor, and Salivary gland;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH RARA AND RXRA.
RX   PubMed=17641689; DOI=10.1038/sj.emboj.7601797;
RA   Lee H.-K., Park U.-H., Kim E.-J., Um S.-J.;
RT   "MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid
RT   receptor activation.";
RL   EMBO J. 26:3545-3557(2007).
RN   [4]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-723, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryo;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
CC   -!- FUNCTION: Component of the Mediator complex, a coactivator involved in
CC       the regulated transcription of nearly all RNA polymerase II-dependent
CC       genes. Mediator functions as a bridge to convey information from gene-
CC       specific regulatory proteins to the basal RNA polymerase II
CC       transcription machinery. Mediator is recruited to promoters by direct
CC       interactions with regulatory proteins and serves as a scaffold for the
CC       assembly of a functional preinitiation complex with RNA polymerase II
CC       and the general transcription factors. Required for RARA/RXRA-mediated
CC       transcription (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Component of the Mediator complex, which is composed of MED1,
CC       MED4, MED6, MED7, MED8, MED9, MED10, MED11, MED12, MED13, MED13L,
CC       MED14, MED15, MED16, MED17, MED18, MED19, MED20, MED21, MED22, MED23,
CC       MED24, MED25, MED26, MED27, MED29, MED30, MED31, CCNC, CDK8 and
CC       CDC2L6/CDK11. The MED12, MED13, CCNC and CDK8 subunits form a distinct
CC       module termed the CDK8 module. Mediator containing the CDK8 module is
CC       less active than Mediator lacking this module in supporting
CC       transcriptional activation. Individual preparations of the Mediator
CC       complex lacking one or more distinct subunits have been variously
CC       termed ARC, CRSP, DRIP, PC2, SMCC and TRAP. Interacts with CREBBP.
CC       Interacts with ESR1, GR and THRB in a ligand-dependent fashion. Binds
CC       the Herpes simplex virus activator VP16 (By similarity). Interacts with
CC       RARA and RXRA in a ligand-dependent fashion. {ECO:0000250,
CC       ECO:0000269|PubMed:17641689}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8VCB2-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8VCB2-2; Sequence=VSP_028147, VSP_028150;
CC       Name=3;
CC         IsoId=Q8VCB2-3; Sequence=VSP_028148;
CC       Name=4;
CC         IsoId=Q8VCB2-4; Sequence=VSP_028149;
CC   -!- SIMILARITY: Belongs to the Mediator complex subunit 25 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK148368; BAE28509.1; -; mRNA.
DR   EMBL; AK149867; BAE29135.1; -; mRNA.
DR   EMBL; BC021333; AAH21333.1; -; mRNA.
DR   EMBL; BC031138; AAH31138.1; -; mRNA.
DR   EMBL; BC071206; AAH71206.1; -; mRNA.
DR   CCDS; CCDS21220.1; -. [Q8VCB2-1]
DR   CCDS; CCDS85291.1; -. [Q8VCB2-2]
DR   RefSeq; NP_001318135.1; NM_001331206.1.
DR   RefSeq; NP_001318137.1; NM_001331208.1. [Q8VCB2-2]
DR   RefSeq; NP_083641.1; NM_029365.3. [Q8VCB2-1]
DR   PDB; 6W1S; EM; 4.02 A; T=15-216.
DR   PDBsum; 6W1S; -.
DR   AlphaFoldDB; Q8VCB2; -.
DR   BMRB; Q8VCB2; -.
DR   SMR; Q8VCB2; -.
DR   BioGRID; 217616; 2.
DR   ComplexPortal; CPX-3264; Core mediator complex.
DR   IntAct; Q8VCB2; 5.
DR   MINT; Q8VCB2; -.
DR   STRING; 10090.ENSMUSP00000003049; -.
DR   iPTMnet; Q8VCB2; -.
DR   PhosphoSitePlus; Q8VCB2; -.
DR   EPD; Q8VCB2; -.
DR   MaxQB; Q8VCB2; -.
DR   PaxDb; Q8VCB2; -.
DR   PeptideAtlas; Q8VCB2; -.
DR   PRIDE; Q8VCB2; -.
DR   ProteomicsDB; 295867; -. [Q8VCB2-1]
DR   ProteomicsDB; 295868; -. [Q8VCB2-2]
DR   ProteomicsDB; 295869; -. [Q8VCB2-3]
DR   ProteomicsDB; 295870; -. [Q8VCB2-4]
DR   Antibodypedia; 45928; 123 antibodies from 20 providers.
DR   Ensembl; ENSMUST00000003049; ENSMUSP00000003049; ENSMUSG00000002968. [Q8VCB2-1]
DR   Ensembl; ENSMUST00000207278; ENSMUSP00000146595; ENSMUSG00000002968. [Q8VCB2-2]
DR   GeneID; 75613; -.
DR   KEGG; mmu:75613; -.
DR   UCSC; uc009grm.1; mouse. [Q8VCB2-2]
DR   UCSC; uc009grn.1; mouse. [Q8VCB2-1]
DR   UCSC; uc009grs.1; mouse. [Q8VCB2-3]
DR   CTD; 81857; -.
DR   MGI; MGI:1922863; Med25.
DR   VEuPathDB; HostDB:ENSMUSG00000002968; -.
DR   eggNOG; ENOG502QRN5; Eukaryota.
DR   GeneTree; ENSGT00940000160439; -.
DR   HOGENOM; CLU_007594_0_0_1; -.
DR   InParanoid; Q8VCB2; -.
DR   OrthoDB; 340324at2759; -.
DR   PhylomeDB; Q8VCB2; -.
DR   TreeFam; TF329598; -.
DR   Reactome; R-MMU-212436; Generic Transcription Pathway.
DR   BioGRID-ORCS; 75613; 14 hits in 73 CRISPR screens.
DR   ChiTaRS; Med25; mouse.
DR   PRO; PR:Q8VCB2; -.
DR   Proteomes; UP000000589; Chromosome 7.
DR   RNAct; Q8VCB2; protein.
DR   Bgee; ENSMUSG00000002968; Expressed in dorsal pancreas and 255 other tissues.
DR   ExpressionAtlas; Q8VCB2; baseline and differential.
DR   Genevisible; Q8VCB2; MM.
DR   GO; GO:0070847; C:core mediator complex; ISO:MGI.
DR   GO; GO:0016592; C:mediator complex; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; ISO:MGI.
DR   GO; GO:0005634; C:nucleus; ISO:MGI.
DR   GO; GO:0005667; C:transcription regulator complex; IPI:MGI.
DR   GO; GO:0042974; F:nuclear retinoic acid receptor binding; IPI:UniProtKB.
DR   GO; GO:0046965; F:nuclear retinoid X receptor binding; IPI:UniProtKB.
DR   GO; GO:0001223; F:transcription coactivator binding; ISO:MGI.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISO:MGI.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0035563; P:positive regulation of chromatin binding; ISO:MGI.
DR   GO; GO:2001178; P:positive regulation of mediator complex assembly; ISO:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IGI:MGI.
DR   GO; GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IC:ComplexPortal.
DR   GO; GO:0060261; P:positive regulation of transcription initiation from RNA polymerase II promoter; IC:ComplexPortal.
DR   GO; GO:0051123; P:RNA polymerase II preinitiation complex assembly; IC:ComplexPortal.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; IGI:MGI.
DR   Gene3D; 2.40.290.30; -; 1.
DR   InterPro; IPR045105; Med25/PTOV1.
DR   InterPro; IPR021394; Med25_PTOV.
DR   InterPro; IPR038196; Med25_PTOV_sf.
DR   InterPro; IPR021406; Mediator_Med25_NR-box.
DR   InterPro; IPR021397; Mediator_Med25_SD1.
DR   InterPro; IPR021419; Mediator_Med25_VWA.
DR   InterPro; IPR036465; vWFA_dom_sf.
DR   PANTHER; PTHR12433; PTHR12433; 1.
DR   Pfam; PF11232; Med25; 1.
DR   Pfam; PF11244; Med25_NR-box; 1.
DR   Pfam; PF11235; Med25_SD1; 1.
DR   Pfam; PF11265; Med25_VWA; 1.
DR   SUPFAM; SSF53300; SSF53300; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Methylation; Nucleus;
KW   Reference proteome; Transcription; Transcription regulation.
FT   CHAIN           1..745
FT                   /note="Mediator of RNA polymerase II transcription subunit
FT                   25"
FT                   /id="PRO_0000304953"
FT   REGION          1..226
FT                   /note="Interaction with the Mediator complex"
FT                   /evidence="ECO:0000250"
FT   REGION          233..266
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          299..374
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          389..543
FT                   /note="Interaction with VP16"
FT                   /evidence="ECO:0000250"
FT   REGION          395..545
FT                   /note="Interaction with CREBBP"
FT                   /evidence="ECO:0000250"
FT   REGION          563..652
FT                   /note="Interaction with RARA"
FT                   /evidence="ECO:0000250"
FT   REGION          584..738
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          639..705
FT                   /note="Interaction with RARA"
FT                   /evidence="ECO:0000250"
FT   MOTIF           645..649
FT                   /note="LXXLL motif"
FT   COMPBIAS        319..345
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        594..614
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        618..636
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        654..678
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         723
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0007744|PubMed:24129315"
FT   VAR_SEQ         1..103
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028147"
FT   VAR_SEQ         102
FT                   /note="K -> KPVLGAEPYPDPARMSNSLSLLPANGIPRKLSSGIVKCRCLLRTSGR
FT                   NPHLEFWEAPRPSLLHIRDGAYEDSTTFGQM (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_028148"
FT   VAR_SEQ         103..745
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:16141072"
FT                   /id="VSP_028149"
FT   VAR_SEQ         558..581
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_028150"
SQ   SEQUENCE   745 AA;  78113 MW;  A8C63CF063BECEEA CRC64;
     MVPGSEGPAR AGGLVADVVF VIEGTANLGP YFEELRKHYL LPAIEYFNGG PPAETDFGGD
     YGGTQYSLVV FNTVDCAPES YVQCHAPTSS AYEFVTWLDG IKFMGGGGES CSLIAEGLST
     ALQLFDDFKK MREQIGQTHR VCLLICNSPP YLLPAVESTT YSGCTTESLV QKIGERGIHF
     SIVSPRKLPA LRLLFEKAAP PALLEPLQQP ADVSQDPRHM VLVRGLVLPV GGSSTSGSLQ
     TKQAVPLPPA PASAATLSAA PPQALPPVPP QYQVPGNLSA AQVAAQNAVE AAKSQKAGLG
     PRFSPINPLQ QAAPGVGPPF SQAPAPPLAP VPPGAPKPPP ASQPSLVSTV APGPVLAAPA
     QPGAPSLAGT VTPGGVNGPS AAQLGGPALG GQQSVSNKLL AWSGVLEWQE KPKPASVDAN
     TKLTRSLPCQ VYVNHGENLK TEQWPQKLIM QLIPQQLLTT LGPLFRNSRM VQFHFTNKDL
     ESLKGLYRIM GNGFAGCVHF PHTAPCEVRV LMLLYSSKKK IFMGLIPYDQ SGFVNGIRQV
     ITNHKQVQQQ KLEQQRGMGA QQAPPVLGPI LEEQARPPQN LLQLRAPQPQ PQGAVGASAA
     TGQPQPQGAT QAPTGAPQGP PGAAPGPPPS GPILRPQNPG ANPQLRSLLL NPAPPQTGVP
     PPQASLHHLQ PPGAPTLLPP HQSMGQPQLG PQLLHPPPAQ SWPTQLPQRA PLPGQMLLSG
     GPRGPVPQPG LQPSVMEDDI LMDLI
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024